Zhitong Finance App News, Shanghai Pharmaceutical (02607.HK) issued an announcement. Recently, hydroxychloroquine sulfate tablets produced by Shanghai Shangyao Zhongxi Pharmaceutical Co., Ltd. (Shangyao Zhongxi), a subsidiary of the company, received a drug registration certificate issued by the Philippine Food and Drug Administration, and the drug was approved for marketing.

Zhitongcaijing · 2d ago
Zhitong Finance App News, Shanghai Pharmaceutical (02607.HK) issued an announcement. Recently, hydroxychloroquine sulfate tablets produced by Shanghai Shangyao Zhongxi Pharmaceutical Co., Ltd. (Shangyao Zhongxi), a subsidiary of the company, received a drug registration certificate issued by the Philippine Food and Drug Administration, and the drug was approved for marketing.